Valuation: Inventage Lab, Inc.

Market Cap	40TCr 29Cr 25Cr 23Cr 21Cr 40Cr 2.76TCr 40Cr 273.2Cr 106.5Cr 1.38TCr 108.24Cr 105.89Cr 4.58TCr	P/E 2024	-11.5x	P/E 2025	-110x
Enterprise Value	40TCr 28Cr 24Cr 23Cr 21Cr 39Cr 2.72TCr 40Cr 269.57Cr 105.08Cr 1.36TCr 106.81Cr 104.48Cr 4.52TCr	EV / Sales 2024	106x	EV / Sales 2025	356x
Free-Float	73.58%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Inventage Lab, Inc.

16/03	Quratis Inc. announced that it has received KRW 10.000000167 billion in funding from Inventage Lab, Inc.	CI
16/03	Inventage Lab, Inc. announced that it has received KRW 89.99724455 billion in funding from a group of investors	CI
09/03	Inventage Lab, Inc. announced that it has received KRW 8.5 billion in funding	CI
06/03	Inventage Lab, Inc. announced that it expects to receive KRW 37.25 billion in funding from a group of investors	CI
06/03	Inventage Lab, Inc. announced that it expects to receive KRW 8.5 billion in funding	CI
06/03	Inventage Lab, Inc. announced that it expects to receive KRW 52.74724455 billion in funding from a group of investors	CI
06/03	Quratis Inc. announced that it expects to receive KRW 10.000000167 billion in funding from Inventage Lab, Inc.	CI
26/02	Inventage Lab, Inc. agreed to acquire an additional 12.79% stake in Quratis Inc. for KRW 13.5 billion.	CI
10/12	Inventage Lab Seeks Approval for Phase 2 Trial of Alopecia Drug in Australia	MT
22/25/22	Inventage Lab, Inc.(KOSDAQ:A389470) added to S&P Global BMI Index	CI
12/25/12	Inventage Lab, Inc. announced that it has received KRW 9.9999925 billion in funding from PEACE to S KOREA Co., Ltd	CI
12/25/12	Quratis Inc. announced that it has received KRW 10.0329 billion in funding from Inventage Lab, Inc.	CI
21/25/21	Quratis Inc. announced that it has received KRW 15 billion in funding from Inventage Lab, Inc.	CI

More news

Managers and Directors: Inventage Lab, Inc.

Manager	Title	Age	Since
Ju-Hee Kim CEO	Chief Executive Officer	52	14/05/2015
Byeong-Yul Jeong DFI	Director of Finance/CFO	55	-
Chan-Hee Jeon CTO	Chief Tech/Sci/R&D Officer	57	-

Director	Title	Age	Since
Ju-Hee Kim BRD	Director/Board Member	52	14/05/2015
Choong-Ho Ryu BRD	Director/Board Member	56	-
Chan-Hee Jeon BRD	Director/Board Member	57	-

More insiders

Inventage Lab Inc is a Korea-based company principally engaged in the pharmaceutical business. The Company owns the platforms applied to the development and mass production of long-acting injections and drug delivery of genetic materials. The Company is engaged in the research, manufacture and sale of human medicines used for male pattern baldness, dementia, prostate cancer and others. It is also engaged in the research, manufacture and sale of veterinary medicines such as combination drugs, chemical castration agents and others.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
20/26/20	₩30,250.00	+0.50%	83,623
19/26/19	₩30,100.00	-1.31%	22,275
18/26/18	₩30,500.00	-4.98%	45,719
14/26/14	₩32,100.00	-0.62%	52,577
13/26/13	₩32,300.00	+2.87%	39,433

End-of-day quote Korea S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. 20/08/2026			5-day change	1st Jan Change
30,250.00 ^KRW	+0.50%		-6.35%	-64.07%

1 day	+0.50%
1 week	-6.35%
Current month	+11.01%
1 month	-2.73%
3 months	-37.11%
6 months	-56.91%
Current year	-64.07%

1 week	29,300	33,550
1 month	22,650	34,650
Current year	22,650	1,01,700
1 year	22,650	1,01,700
3 years	9,400	1,01,700
5 years	8,440	1,01,700
10 years	8,440	1,01,700

Date	Insider	Type	Quantity	% Market Cap.
08/08/25	Dong Seok Park	Fiscal year	8,000	0.0796%
08/08/25	Se Yeon Kim	Fiscal year	10,000	0.0996%
08/08/25	Dong Seok Park	Fiscal year	8,000	0.0796%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INVENTAGE LAB, INC.	+0.50%	-6.35%	-3.20%	+39.40%	29Cr
ELI LILLY AND COMPANY	-2.81%	+2.93%	+76.40%	+127.73%	1,10900Cr
JOHNSON & JOHNSON	-2.21%	+2.02%	+49.50%	+55.01%	64TCr
ABBVIE INC.	-1.56%	+4.39%	+25.19%	+74.39%	46TCr
ROCHE HOLDING AG	-1.37%	+3.29%	+39.73%	+44.24%	37TCr
NOVARTIS AG	-0.91%	+2.22%	+21.68%	+39.07%	30TCr
ASTRAZENECA PLC	-0.89%	+4.50%	-0.60%	+12.20%	26TCr
AMGEN INC.	-1.95%	+3.80%	+46.31%	+65.66%	23TCr
NOVO NORDISK A/S	-0.04%	+0.42%	-16.89%	-53.07%	20TCr
GILEAD SCIENCES, INC.	-2.82%	+3.84%	+20.81%	+89.04%	18TCr
Average	-1.41%	+2.07%	+25.89%	+49.37%	37.61TCr
Weighted average by Cap.	-1.93%	+3.26%	+42.67%	+69.98%

Inventage Lab, Inc. Share Price

Stocks

A389470

KR7389470006

Pharmaceuticals

Valuation: Inventage Lab, Inc.

Chart: Inventage Lab, Inc.

Latest news : Inventage Lab, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Inventage Lab, Inc.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

	2024	2025
Net sales	178.29Cr 12.8L 10.96L 10.22L 9L 17.63L 12Cr 17.97L 1.21Cr 47.28L 6.14Cr 48.05L 47L 20Cr	293.88Cr 21.09L 18.06L 16.85L 15.46L 29.05L 20Cr 29.63L 2Cr 77.92L 10Cr 79.2L 77.48L 33Cr
Net income	-1.7TCr -1.22Cr -1.04Cr -97.45L -89.42L -1.68Cr -116.73Cr -1.71Cr -12Cr -4.51Cr -58Cr -4.58Cr -4.48Cr -193.67Cr	-845.84Cr -60.71L -51.98L -48.5L -44.5L -83.62L -58Cr -85.27L -5.75Cr -2.24Cr -29Cr -2.28Cr -2.23Cr -96Cr
Net Debt	-2.4TCr -1.72Cr -1.47Cr -1.37Cr -1.26Cr -2.37Cr -164.58Cr -2.42Cr -16Cr -6.35Cr -82Cr -6.46Cr -6.32Cr -273.07Cr	-532.71Cr -38.24L -32.74L -30.54L -28.03L -52.66L -37Cr -53.7L -3.62Cr -1.41Cr -18Cr -1.44Cr -1.4Cr -61Cr